Cover Image
市場調查報告書

多形性紅斑:全球臨床實驗檢討

Erythema Multiforme Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 296483
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
多形性紅斑:全球臨床實驗檢討 Erythema Multiforme Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月28日 內容資訊: 英文 37 Pages
簡介

本報告提供全球多形性紅斑治療藥臨床實驗的相關調查,彙整各地區,各階段,各狀態臨床實驗趨勢,正在開發的藥物概要等資料,為您概述為以下內容。

目錄

簡介

各地區臨床實驗

  • 各國家臨床實驗
    • 亞太地區的前幾名國家
    • 歐洲的前五名國家
    • 北美的前幾名國家
    • 中南美的前幾名國家

G7各國臨床實驗

E7各國臨床實驗

各階段臨床實驗

各狀態臨床實驗

一定期間內募集的實驗對象

  • 贊助商各類型臨床實驗

主要的贊助商

  • 多形性紅斑臨床實驗參與計劃主要企業

主要藥物

臨床實驗簡介

  • 主要企業
    • Galderma S.A.
    • Bayer AG
    • Recordati S.p.A.
    • DeNova Research
    • Allergan, Inc.
  • 大學·機關·醫院
    • 橫?市立大學
    • Fondazione IRCCS - Istituto Nazionale dei Tumori
    • Universidade de Pernambuco
    • Mahidol University
    • University of California, San Diego

5個主要的臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3759CTIDB

GlobalData's clinical trial report, "Erythema Multiforme Global Clinical Trials Review, H2, 2016" provides an overview of Erythema Multiforme clinical trials scenario. This report provides top line data relating to the clinical trials on Erythema Multiforme. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Erythema Multiforme to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials by E7 Countries: Proportion of Erythema Multiforme to Dermatology Clinical Trials
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Erythema Multiforme Therapeutics Clinical Trials
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Erythema Multiforme Therapeutics, Global, Clinical Trials by Region, 2016*
  • Erythema Multiforme Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Europe, Top Countries, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Proportion of Erythema Multiforme to Dermatology Clinical Trials, G7 Countries (%), 2016*
  • Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Proportion of Erythema Multiforme to Dermatology Clinical Trials, E7 Countries (%), 2016*
  • Erythema Multiforme Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Erythema Multiforme Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Erythema Multiforme Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*

List of Figures

  • Erythema Multiforme Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Erythema Multiforme Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Europe, Top Countries (%), 2016*
  • Proportion of Erythema Multiforme to Dermatology Clinical Trials, G7 Countries (%), 2016*
  • Erythema Multiforme Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Proportion of Erythema Multiforme to Dermatology Clinical Trials, E7 Countries (%), 2016*
  • Erythema Multiforme Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Erythema Multiforme Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Erythema Multiforme Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Erythema Multiforme Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • GlobalData Methodology
Back to Top